Evaluation of the Office on Violence Against Women's Domestic Violence Homicide Prevention Demonstrative Initiative
The purpose of this project is to evaluate the Office on Violence Against Women's (OVW) Domestic Violence Homicide Prevention Demonstration Initiative.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Evaluation of the Domestic Violence Homicide Prevention Initiative|
- reductions in DV homicides [ Time Frame: up to 4 years ] [ Designated as safety issue: Yes ]Whether there were reductions in DV homicides
- Near Lethality [ Time Frame: up to 4 years ] [ Designated as safety issue: Yes ]Attempting to suffocate, drown, beat to death (left for dead) blunt instrument like a bat. Also simply like someone charged with attempted murder as the most serious charge. Mainly police reports, supplemarely materials like newspaper, ER reports
- Collateral Killing [ Time Frame: up to 4 years ] [ Designated as safety issue: Yes ]people that killed beyond the focal victim mainly police reports. materials like newspaper, ER reports
|Study Start Date:||January 2014|
|Estimated Study Completion Date:||December 2017|
|Estimated Primary Completion Date:||December 2017 (Final data collection date for primary outcome measure)|
|Contra Costa County, California|
|Miami-Dade County, Flordia|
|Palm Beach County, Flordia|
|Rockdale County, Georgia|
|Winnebago County, lIlinois|
|Brooklyn, New York|
|Westchester County, New York|
|Pitt County, North Carolina|
|Cuyahoga County, Ohio|
|North Charleston, South Carolina|
During Phase I, 12 sites assessed their structures and processes for addressing domestic violence. In Phase II, up to six sites will implement their work plans to test changes to existing procedures, practices, and structures related to domestic violence homicide prevention. This evaluation will assess the processes and outcomes within and across sites.
As this is an evaluation of models carried out by Phase II sites, the "subjects" are the six funded sites. Research Design and Methods: The national evaluation will be a utilization-focused developmental evaluation-"utilization-focused" in that the project will be done for and with primary intended users of the evaluation findings; "developmental" in that the intended use is development of domestic violence homicide prevention models. Process evaluation will focus on the internal dynamics and actual operations of domestic violence homicide prevention programs at Phase II sites. This will be achieved primarily through the use of system dynamics modeling, which uses computer simulation to understand the behavior of complex systems over time. Outcome evaluation will examine the intended and unintended consequences of the prevention programs. This will be carried out largely through the use of multilevel modeling, which takes into account multiple sources of variation when estimating differences in outcomes between sites.
System dynamics modeling within and across sites will progress through a series of iterative steps involving problem articulation, formulation of a dynamic hypothesis, development of a computer simulation model, validation and model testing, and policy design and recommendations. Multilevel modeling will take into account individual- (victims and perpetrators), intimate partner relationship-, and site-level variables in estimation of between site variation in outcomes. Cost-effectiveness analyses will include an assessment of the cost-effectiveness of the overall initiative, as well as sub-analyses comparing cost-effectiveness of individual sites whose prevention programs proved effective.
Products, Reports, and Data Archiving:
The investigators will produce a final report providing a comprehensive overview of the national evaluation and its findings. The investigators will also provide quarterly financial reports as well as semi-annual progress reports. The final project submission will also include data files with original and transformed data variables; statistical analysis software syntax that documents the analysis process; files that document the system dynamics models; and a data and research guidebook as specified in the archiving plan.
Please refer to this study by its ClinicalTrials.gov identifier: NCT02021838
|Contact: Christal M Espositoemail@example.com|
|United States, Connecticut|
|New Haven, Connecticut, United States, 06513|
|Contact: Christal M Esposito 203-737-3313 firstname.lastname@example.org|
|Principal Investigator:||Lori A Post, PhD||Yale University|